#Low Density Lipoprotein (LDL) Test Market Share | Explore Tumblr Posts and Blogs

leftcomputerpost · 3 years

Text

Apolipoprotein Test Market Important Changes in Industry Dynamics during 2020-2031

Apolipoprotein Test Market Overview

This Apolipoprotein Test Analysis market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Apolipoprotein Test Analysis market.

Apolipoproteins are proteins that transport by binding to them. There are several types of apolipoproteins out of which Apolipoprotein B are the major forms of protein which originate from Low-Density Lipoproteins (LDL). Two forms of Apo B are found in humans. Apo B100 help to evaluate the risk of developing cardiovascular disease whereas Apo B48 is useful in the observation of lipid-soluble nutrients and drugs. Apo A and Apo C3 are responsible for controlling heart conditions. Apolipoprotein test market is expected to significantly increase because of the increased risk of developing cardiovascular diseases in most of the adults having high cholesterol. Such tests are performed to determine developing risks of cardiovascular disorders as earliest as possible. Apolipoprotein test market is expected to high growth markets because of increasing risks of developing severe heart disorders such as stroke and heart attack. According to the World Health Organization, around 85% of all cardiovascular disease-related deaths are due to heart attacks and strokes and around 17.9 million people die each year from CVDs. Major apolipoproteins, apoA and apoB are mainly associated with CVD. Other apolipoproteins such as apo D, apoE and apoJ are associated with Alzheimer’s disease whereas apoM is concerned with atherosclerosis, diabetes and renal disease. Hence minor increase or decrease in such apolipoproteins may lead to CVDs indicating there are huge opportunities in apolipoprotein test market.

Apolipoprotein Test Market: Drivers and Restraints

Increasing demand for diagnostic services in the developing region is expected to be one of the major causes of driving the growth of apolipoprotein test market. Increased awareness about maintaining good cardiac health can also be the growth factor for apolipoprotein test market. Unhealthy lifestyle habits are leading to various serious cardiovascular disorders such as coronary heart disease, high blood pressure, cardiac arrest, heart failure, stroke, arrhythmia and many other diseases also leads to boost apolipoprotein test market. Apolipoprotein test is nowadays recommended by most of the physicians, heart specialists and health care providers to the patients having a personal family history of heart disease. Hence, recommendation of apolipoprotein tests by medical practitioners to the patients having a family history of heart disease is considered to be the noticeable factors driving the growth of apolipoprotein test market. Physicians also recommend apolipoprotein test to the patients having high levels of cholesterol. Because of health education and high awareness among people about an increased risk of developing heart diseases people tend to perform apolipoprotein tests once or twice in a year, this can also be the driving factor for the growth of apolipoprotein test market.

Apolipoprotein Test Market: Overview

A rise in healthcare expenditure, improved health consciousness and health awareness are anticipated to be the leading causes to drive the growth of apolipoprotein test market. Increased access to healthcare and the wider availability of healthcare and diagnostic services are also expected to contribute to the growth of apolipoprotein test market. Healthcare and diagnostic services are more in demand in developing regions. Hence, health care providers and diagnostic centres are expected to have more growth opportunities in developing countries. Cardiovascular disease being a leading global cause of death is expected to surge the growth of apolipoprotein test market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10749

Apolipoprotein Test Market: Key Market Participants

Apolipoprotein test market includes key market participants such as Randox Laboratories Ltd., Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., Myriad Genetics Inc., Quest Diagnostics Inc., and Eurofins Scientific, Lincoln Diagnostics LLC, DiaSorin S.p.A. Boster Biological Technology, Ltd. Rockland Immunochemicals Inc.

The report covers exhaust analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)

Asia Pacific (India, China ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-10749

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: [email protected] For Media Enquiries: [email protected] Website: https://www.futuremarketinsights.com

0 notes

marketreports-world · 3 years

Text

Global Low-density Lipoprotein Test Market - Forecast Till 2027

LDL Test Market Information: By Types (LDL-C, LDL-P, LDL-B And Others) By Components (Devices, Kits & Reagents And Others) By Application (Atherosclerosis, Obesity, Dyslipidemia, Diabetes, Angina, Stroke, Carotid Artery Disease, Peripheral Arterial Disease, Others) And By End Users- Global Forecast Till 2027

Market Highlights:

LDL is referred as low-density lipoprotein, which is type of cholesterol found in body. Low-density lipoprotein (LDL), often known as bad cholesterol, is a microscopic blob made up of an outer rim of lipoprotein and a cholesterol center. It's bad because it becomes part of plaque, and that can clog arteries and make heart attacks and strokes more likely. The major driving factor for the market are increasing prevalence of obesity, deskbound lifestyle and lack of exercise. According to OMICS International, atherosclerosis account for 32% of total deaths in the world, out of which, 13.8% prevalence is among adults of 20 years and above. The cases of heart failure were estimated about 30% across the globe. Coronary heart disease mortality rate was about 60% in 2010. In addition to this, increasing healthcare expenditure, increasing awareness among the people and government initiatives for research and development have fuelled the market growth. The global LDL test market is projected to grow at a CAGR of ~ 5.5 % during the forecast period 2017-2023.

Key Market Players

Quest Diagnostics Incorporated, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckon Diagnostics, DiaSys Diagnostics India Private Limited, F. Hoffmann-La Roche Ltd and others.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4215

Regional Analysis

Geographically, the global LDT test market is segmented into Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas account for a significant market share owing to extensive use of medications, high expenditure on the health care, huge patient population and increasing government support for research & development. Also, major research and manufacturing companies are present in America.

Europe is the second largest market in the world due to high income, government support for research & development and availability of resources.

Asia Pacific region shows the fastest growth owing to the presence of huge population base, and continuous development in the healthcare sector. China and India are likely to lead this market due to fast growing healthcare sector during the forecasted period.

On the other hand, the Middle East & Africa has the least market share due to limited development in the healthcare sector. Middle East holds a major share for the market due to presence of gulf nations such as Saudi Arabia and the UAE. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global LDL test Market” Research Report – Forecast till 2023.

Segmentation

The global LDL test market has been segmented on the basis of types, components, applications and end users.

Based on types, the market has been segmented into LDL-C, LDL-P, LDL-B and others.

Based on components, the market has been segmented into devices, kits & reagents and others. Devices is further sub-segmented into syringes & needles, spectrophotometers and others. And kits & reagents is further sub-segmented into toxicity assays kit, blood chemistry assays kit, cytotoxicity assays kit.

Based on application, the market has been segmented as atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.

Based on the end users, the market has been segmented as hospitals and clinics, pharmaceutical and biotechnological companies and others.

Table Of Contents

1. Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2. Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global LDL Test Market, By Types

5.1 Introduction

5.2 LDL-C

5.3 LDL-P

5.4 LDL-B

5.5 Others

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/ldl-test-market-4215

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

#Low-density Lipoprotein Test

0 notes

market-research-future · 4 years

Text

Cholesterol Management Devices Market Landscape, Overview and Segmentation

Cholesterol Management Devices Market Share, Growth And Trends Analysis By Types (Monitors, Wrist Monitors, Small Portable Instruments, Meters, Wireless Systems), By Application (Hypercholesterolemia, Hypocholesterolemia, Cholesterol Testing), By End Users (Home Healthcare, Hospitals, And Clinics) - Global Forecast Till 2023

Cholesterol Management Devices Market Regional Analysis

America accounts for the largest share of the global market followed by Europe. The presence of a huge population suffering from obesity and hypercholesterolemia has driven the growth of the market in America. While, the government support for research and development, well-developed technology, and higher healthcare expenditure have uplifted the growth of the market in Europe and expected to continue over the forecast period. Asia Pacific experiencing the fastest growth in the market owing to the presence of rapidly growing economies, and a large population base. The Middle East & Africa has the least share in the global market due to the presence of poor infrastructure and less developments in the healthcare sector especially, in the African region.

Currently, the global cholesterol management devices market is experiencing extreme competition due to leading companies are focusing on the development of new and advanced monitoring devices to overcome the disadvantages of other available devices. Some of the market players are responding to these new opportunities by expanding their global presence and service offerings/product lines.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4160

Geographically, the global cholesterol management devices Market is categorized into America, Europe, Asia Pacific and the Middle East & Africa.

Abbott, headquartered in the US, is one of the leading healthcare company. The company manufactures, ARCHITECT, which is a clinical chemistry analyzer provides the excellent first-time results. The company performs several tests for high-density lipoprotein (HOL), low-density lipoprotein (LDL), and triglycerides.

Medtronic, headquartered in the UK, is the world's largest medical devices manufacturer. Till now, the company has launched several portable monitoring devices used in the hospitals. In 2015, the company acquired Covidien.

Market Key Players

Some of the key player in the cholesterol management devices Market are Boston Scientific Corporation (US), Medtronic (US), St. Jude Medical, LLC. (Canada), Koninklijke Philips N.V. (US), Roche Diagnostics (US), Abbott (US), Alere (US), Sorin Group (Italy), BIOTRONIK SE & Co. KG (Germany), Bio-AMD (UK) and others.

The Global cholesterol management devices market by size and share is projected to grow at a CAGR of 8.5% during the forecasted period 2017-2023.

Market Highlights

Cholesterol management devices are the monitoring devices for the determination of the cholesterol levels in the body. Cholesterol is one of the vital constituents of the cells. However, increase in the cholesterol level may lead to atherosclerosis, cardiovascular diseases, heart attack, and other diseases.

The global cholesterol management devices market is driven by rapid development in the cholesterol monitoring devices, and increasing people suffering from obesity. Moreover, affordability of the devices, poor diet and less physical activity, desk-bound nature of work, changing modes of transportation, and increasing urbanization have also contributed to the growth of the market. However, lack of awareness among the people may obstruct the growth of the market.

Cholesterol Management Devices Market Segmentation:

The global cholesterol management devices Market is segmented based on types, applications, and end users. Based on types, the market is classified into monitors, wrist monitors, small portable instruments, meters, wireless systems, and others. On the basis of applications, the market is categorized into hypercholesterolemia, hypocholesterolemia, cholesterol testing, and others. Based on end users, the market is segmented into home healthcare, hospitals, clinics, and others.

Browse Detailed Table of Content at: https://www.marketresearchfuture.com/reports/cholesterol-management-devices-market-1045

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Brows More Healthcare Related Research Reports

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

Nanobots Market Size, Trends | Insights and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

andreassatterwhi-blog · 6 years

Text

The Facts About LDL, The Dangerous Form of Cholesterol

You need to have a standard lipid panel which appears your whole cholesterol, the "bad" low-density lipoprotein (LDL) cholesterol and the "good" excessive-density lipoprotein (HDL) cholesterol. High-density lipoprotein (HDL). You need this worth to be high. This drug would increase HDL and lower TG without very much effect on the LDL. High levels of HDL cholesterol can decrease your threat for heart illness and stroke. Researchers have solely lately developed strategies for testing levels of oxidized LDL. I undoubtedly might be sharing a great deal of what you could have written so that I too can change lives and help others! The cholesterol-decreasing results of a healthy diet, for example, will be amplified when coupled with regular train and a set sleep schedule. Two common sorts of cholesterol-reducing medications are "statins" and "fibrates". This widespread nutritional advice is true for individuals who eat a excessive-carbohydrate weight-reduction plan. Individuals who exercise usually are much less inclined to syndrome X and weight achieve.

That’s why I added a new software for individuals to verify their Remnant Cholesterol right here on the site. Use our useful Verify. In addition, contemporary grapes present different coronary heart-protecting nutrients including vitamin C, vitamin B6, potassium, and flavonoids. When given in very high doses, vitamin B3 can reduce LDL cholesterol and triglycerides. Cholesterol is a fats-like substance that the body makes use of to make healthy cell walls, other tissues, hormones, vitamin D and bile acid, which helps you digest your food correctly. The brand new view on cholesterol in food does not reverse warnings about high levels of "bad" cholesterol in the blood, which have been linked to heart illness. Search for the words "entire grains" or "100 per cent whole wheat" on your food labels. Search for different sources of Meats are good sources of protein. Statins are the most widely-used drugs to treat high cholesterol. They really feel that this stage is nice for improving your coronary heart health however do not recommend utilizing medicine to achieve this stage. Patients who are already suffering from vascular disease or have associated systemic diseases are inspired to decrease their LDL levels far beneath even the optimum stage for wholesome adults. A super whole cholesterol stage ranges from 140 to 200mg/dl. When it reaches 300, the danger of getting a coronary heart assault greater than doubles. Then the 2 of you'll develop a technique for decreasing that risk. "A individual can have the most beautiful lipid panel however they will have an elevated Lp-PLA2 which places them at a very excessive danger for having a cardiac event," he said. The outcomes tell you the way much cholesterol you've got in your blood. Unsaturated fats (polyunsaturated and monounsaturated) are found largely in plants, and are less possible to lift blood cholesterol levels. If altering your diet isn’t sufficient, sure supplements may help improve your cholesterol levels. Change your weight loss plan and life-style to help enhance your ranges. Nevertheless, others have been extra pessimistic of those findings, maybe because they didn't feel that the American inhabitants would be keen to dramatically change their current way of life and dietary habits. Find out what the science says about dietary supplements marketed for improving cholesterol. Saturated fatty acids are the principle dietary culprit in raising blood cholesterol. Blood cholesterol checks can be "fasting" or "non-fasting". Most standard docs across the nation urge all adults over the age of 20 to bear common cholesterol screenings to assist monitor whole blood cholesterol numbers. The Jichi Medical Faculty Cohort Research is considered one of the newest, large epidemiological studies performed in Japan in which 12,234 healthy adults from rural communities had been adopted for almost 12 years. Keep records. I was taking Lipitor for 12 years. What's changed in the previous few years is the ubiquity of smartphones. While there might be unfavorable well being effects related to low cholesterol, cholesterol deficiency is rare. Plants solely make hint quantities of cholesterol, however make different sterols in bigger quantities. Plants comprise no cholesterol. How high is excessive cholesterol? Studying learn how to lower cholesterol naturally is straightforward. The HDL, additionally known as the great cholesterol will clear the arteries of the unhealthy cholesterol by transmitting it to the liver. Unfortunately, neither will give you the same advantages. As soon as LDL will get oxidized sufficient, presumably it can wind up in arterial plaque. The whole nutrient density of a food, such as the egg, as well as the way it is grown, raised and ready is what will decide its health profit or detriment. Julie Revelant is a health journalist and a guide who offers content material marketing and copywriting providers for the healthcare industry. Seek the advice of along with your doctor about working up to around half-hour of brisk train each day. Within the age of low-cholesterol diets, heart disease has only risen, not dropped. Can life-style adjustments reverse coronary coronary heart disease? Eating lean cuts of meats and trimming visible fats and skin from meat earlier than cooking can lower saturated fats intake. If you have any concerns pertaining to where and the best ways to use penurun kolesterol ampuh, you can contact us at our own web site.

0 notes

kisan512posts · 4 years

Text

Global Cardiac Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends and Forecast - 2026

Cardiac Biomarkers Industry

Description

Wiseguyreports.Com Adds “Cardiac Biomarkers -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

This chapter summarizes the global market value, market growth rates and key market drivers and restraints and identifies the key suppliers of both centralized laboratory and point-of-care testing. During the past 40 years, blood cardiac biomarkers have become increasingly accurate for evaluating cardiac abnormalities. With an initial focus on myocardial infarction (MI), the use of creatinine kinase- MB (CK-MB), first described in 1972, was a major step forward in the development of a highly specific biomarker. The introduction of cardiac troponin (cTn) assays in 1989 was the next major advance, and the current definition of AMI is centered on subsequent refinement of the assays. This progression ironically brought considerable difficulties to critical care physicians who deal with multiorgan failure rather than patients presenting to the emergency department with chest pain or single-organ pathology. The recent penetration of high sensitivity (hs) cTn, which replace fourth-generation cTn assays, further compounds these diagnostic challenges.

The global cardiac biomarkers market has grown to $4.9 billion in 2015 from $4.4 billion in 2014. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 12.4% from 2015 to 2020, increasing to over $8.8 billion in 2020.

ALSO READ https://www.openpr.com/news/1108597/Cardiac-Biomarkers-Global-Market-2018-Key-Players-Abbott-Laboratories-Biom-rieux-S-A-Bio-Rad-Laboratories-Inc-Life-Diagnostics-Inc.html

Report Scope

The principal objectives of this report are to: – Identify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic testing market. – Obtain a complete understanding of the leading cardiac markers and their value in terms of diagnostic testing, screening, prognostic monitoring, pharmacogenomic testing, and theranostics, while also appreciating these elements from their basic principles to their applications. – Discover feasible market opportunities via identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest-expanding markets for diseases. – Focus on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth. – Present market figures for the current value of the cardiac marker testing market, projections and growth rates. These are taken from the most recently available from the global diagnostics industry.

By purchasing this study, the reader will gain: – An improved understanding of the current state and future of the most exciting cardiac marker diagnostic testing market segments. – The latest information on the leading companies engaged in research and development (R&D) and products in the cardiac marker diagnostic reagent pipeline with SWOT analyses. – A leading perspective of recent diagnostic test developments and revelations as well as knowledge of how they will influence selected clinical markets. – Knowledge of the cardiac diagnostic testing market as an area of growth, research and investment.

This analysis covers the following categories of the cardiac diagnostic testing segments: – AMI. – Heart failure. – Brain natriuretic peptide (BNP). – Myoglobin. – Homocysteine (Hcy). – C-reactive protein (CRP). – Pulmonary embolism (PE) D-dimer test. – Low-density lipoproteins (LDL) and high-density lipoproteins (HDL). – Stroke. – Creatine kinase-myocardial band (CK-MB) and cardiac enzymes. – Albumin. – Cardiac markers used in clinical decisions. – Cardiac markers in renal failure. – Troponins in non-ischemic heart disease. – Cardiac panels. – POC cardiac markers.

Analyses include charts and graphs measuring product growth and trends within the marketplace. In addition, a discussion of research on various illnesses provides the reader with a deeper understanding of the possibilities for future treatment and avenues for possible R&D budgets. Company-specific information, including sales figures, product pipeline status and R&D trends, is provided throughout the report. In addition, the study:

– Assesses cardiac marker diagnostic testing market drivers and bottlenecks from the perspective of the medical and scientific communities. – Discusses the potential benefits of the cardiac marker diagnostic testing market for various sectors of the medical and scientific community. – Establishes the current total market size and future growth of the cardiac marker diagnostic testing market and analyzes the current size and growth of individual segments. – Provides current and forecasted market shares by company. – Discusses profit and business opportunities by diagnostic testing segment. – Provides strategic recommendations for near-term business opportunities. – Assesses current commercial uses of the cardiac marker diagnostic testing market.

Report Includes

– 64 data table and 40 additional tables – An overview of the global market for cardiac biomarkers and related technologies – Analyses of global market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022 – Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease – Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT) – Examination of the technology regarding diagnostic methods, instrumentation, newly issued patents, and new patent applications – Coverage of clinical guidelines and government regulations – Comprehensive company profiles of major Players in the Market including Abbott Laboratories, Biomérieux S.A., Bio-Rad Laboratories Inc, Life Diagnostics Inc., Meridian Life Science Inc. Randox Laboratories Ltd., Roche, Sanyo Chemical Industries Ltd., Siemens Ag, and Thermo Fisher Scientific Inc.

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3260776-cardiac-biomarkers-technologies-and-global-markets

Table of Contents

Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Cardiovascular Disease and Burden of Cardiovascular Disease Chapter 4 Introduction to Cardiac Biomarkers Chapter 5 Review of Key Individual Cardiac Biomarkers Chapter 6 Global Cardiac Biomarker Market Analysis Chapter 7 Regulatory and Legislative Requirements for Cardiac Biomarkers Chapter 8 Patent Review and New Developments for Cardiac Biomarkers Chapter 9 Company Profiles ABBOTT LABORATORIES ACS BIOMARKER BV BECKMAN COULTER (PART OF DANAHER) BG MEDICINE INC. BIOMERIEUX S.A. BIO-RAD LABORATORIES INC. CARDIOGENICS CAVADIS CRITICAL DIAGNOSTICS CRUINN MEDICAL LTD. HEALTH-CHEM DIAGNOSTICS LIFE DIAGNOSTICS INC. LIFESIGN LSI MEDIENCE CORP. MERIDIAN LIFE SCIENCE INC. METANOMICS HEALTH GMBH MIRNEXT ORTHO-CLINICAL DIAGNOSTICS INC. PTS DIAGNOSTICS RADIOMETER MEDICAL APS RANDOX LABORATORIES LTD. RESPONSE BIOMEDICAL CORP. ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.) SANYO CHEMICAL INDUSTRIES LTD. SIEMENS AG SINGULEX INC. SPECTRAL MEDICAL, INC. THERMO FISHER SCIENTIFIC TOSOH BIOSCIENCE INC. TRINITY BIOTECH PLC ZENOSENSE INC. Chapter 10 Appendix A: Company Addresses and Contact Details Chapter 11 Appendix B: Government Regulatory Agencies and Professional Organizations

Continued…

0 notes

marketresearchlove-blog · 4 years

Text

Asia-Pacific LDL Test Market – Industry Trends and Forecast to 2026

Asia-Pacific LDL Test Market By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026

Low density lipoprotein (LDL) is known as bad cholesterol because it is build-up of extra fat in arteries. This condition narrows the arteries and raises the risk of heart attack, stroke and peripheral artery disease. So for the determination of LDL, various kits, reagent and devices are used. For instance N-geneous LDL cholesterol calibrator which used as LDL test for determination of low density lipoprotein for measuring risk of heart diseases. It is basically for in-vitro diagnostic use. These circular particles serve to solubilize and transport cholesterol and triglyceride in the blood stream. The relative proportions of protein and lipid calculates the density of this lipoprotein. The test LDL cholesterol acts as a key factor for determine pathogenesis of atherosclerosis and coronary heart disease. By the use of this test can easily find out associated risk for heart diseases.

Asia-Pacific LDL test market is projected to grow with a healthy CAGR in the forecast period of 2019 to 2026.

Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-ldl-test-market

Segmentation: Asia-Pacific LDL Test Market

Asia-Pacific LDL test market is segmented into four notable segments such as component, disease, end user, distribution channel.

· On the basis of component, the market is segmented into devices, kits & reagents and services. Devices are further segmented into spectrophotometer, syringes & needles, others.

· On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.

· On the basis of distribution channel, the market is segmented into direct tenders and retail.

· On the basis of end user, the market is segmented into hospitals, clinics, research laboratory, and ambulatory care.

Asia-Pacific Aluminum Casting Market Size, Status and Forecast 2018 – 2025

· Asia-Pacific Aluminum Casting Market Overview

· Asia-Pacific Aluminum Casting Market Manufacturers Profiles

· Asia-Pacific Aluminum Casting Market Sales, Revenue, Market Share and Competition by Manufacturer

· Asia-Pacific Aluminum Casting Market Analysis by Regions

· Asia-Pacific Aluminum Casting Market by Countries

· Asia-Pacific Aluminum Casting Market Segment by Type

· Asia-Pacific Aluminum Casting Market Segment by Application

· Asia-Pacific Aluminum Casting MarketForecast

· Sales Channel, Distributors, Traders and Dealers

· Research Findings and Conclusion

· Appendixes

Get Detailed Toc @https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-ldl-test-market

Competitive Analysis: Asia-Pacific LDL Test Market

Some of the major players operating in this market are Quest Diagnostics, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckondiagnostics, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Abbott, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc., Laboratory Corporation of America, Cell Biolabs, Inc., Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc., Home Access Health and others.

Product Launch

· In October 2018, Laboratory Corporation of America (U.S) enabled health record on iPhone. This feature is beneficial for patients to access their LabCorp laboratory test results, along with other available medical data from multiple providers. It enables the patients in receiving the notifications when their data is updated. Patients can access other convenient tools including appointments and payment of invoices as well. With this innovative technology, the company enhances their business.

· In September 2017, Quest Diagnostics (U.S) entered into cholesterol testing for identifying the risk of heart disease and opt right treatment decision. The company’s cholesterol test services which include an innovative calculation method to improve the accuracy of testing for LDL level causing cardiovascular disease.

Speak-to-analyst@

Immunoassay Reagents and Devices Market Country Level Analysis

Immunoassay reagents and devices market is analysed and market size information is provided by country, product, platform, technique, specimen type, application and end user.

The countries covered in the Asia-Pacific market report are China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines and rest of Asia-Pacific.

In Asia-Pacific, China is dominating due to high population with high prevalence of diseases among people for which diagnosis is required. In order to help in diagnosis as well as drug discovery, immunoassay products providing companies are launching new products in china. For instance, Shenzhen mindray bio-medical electronics co., ltd. (China) has launched CLIA analyzer called MAGLUMI 4000 Plus. In 2017, the company has achieved FDA clearance and became 1st CLIA manufacturer in China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strong Investment in Research and Development Activities and New Technology Penetration

Asia-Pacific immunoassay reagents and devices Market also provides you with detailed market analysis for every country growth in medical and pharmaceutical industry with immunoassay reagent and device product sales, therapy devices sales, impact of technological development in devices and dressings and changes in regulatory scenarios with their support for the immunoassay reagents and devices market. The data is available for historic period 2010 to 2018.

Research Methodology: Asia-Pacific LDL Test Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

Buy Now @https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-ldl-test-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

RELATED REPORTS

· Global LDL Test Market - Industry Trends and Forecast to 2026

· Europe LDL Test Market – Industry Trends and Forecast to 2026

· Middle East and Africa LDL Test Market – Industry Trends and Forecast to 2026

#Asia-Pacific LDL Test Market #Asia-Pacific LDL Test Market forcast

0 notes

kritikarehani · 4 years

Text

Hypercholesterolemia Market Share & Size, Epidemiology and Forecast till 2030

Hypercholesterolemia is the most commonly occurring disorder, which results in comorbid conditions, mainly cardiovascular disorders. High levels of low-density lipoprotein (LDL) cholesterol results into an accumulation of cholesterol-rich fatty deposits in arteries resulting in a narrow or blocked flow of blood to vital organs, especially the heart and brain. The Hypercholesterolemia treatment paradigm, which further includes sub-types, such as Homozygous and Heterozygous Familial Hypercholesterolemia holds several options available in the market, i.e., statins, bile-acid-binding resins, cholesterol absorption inhibitors, combination cholesterol absorption inhibitor with statin and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors as well as Injectable medications.

DelveInsight's "Hypercholesterolemia - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Hypercholesterolemia, historical and forecasted epidemiology as well as the Hypercholesterolemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Hypercholesterolemia market report provides current treatment practices, emerging drugs, Hypercholesterolemia market share of the individual therapies, current and forecasted Hypercholesterolemia market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Hypercholesterolemia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered

· The United States

· EU5 (Germany, France, Italy, Spain, and the United Kingdom)

· Japan

Study Period: 2017-2030

Hypercholesterolemia Disease Understanding and Treatment Algorithm

The DelveInsight Hypercholesterolemia market report gives a thorough understanding of the Hypercholesterolemia by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Hypercholesterolemia.

Treatment

It covers the details of conventional and current medical therapies available in the Hypercholesterolemia market for the treatment of the condition. It also provides Hypercholesterolemia treatment algorithms and guidelines in the United States, Europe, and Japan.

Hypercholesterolemia Epidemiology

The Hypercholesterolemia epidemiology division provide insights about historical and current Hypercholesterolemia patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Hypercholesterolemia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

Country Wise- Hypercholesterolemia Epidemiology

The epidemiology segment also provides the Hypercholesterolemia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Hypercholesterolemia Drug Chapters

Drug chapter segment of the Hypercholesterolemia report encloses the detailed analysis of Hypercholesterolemia marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Hypercholesterolemia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Hypercholesterolemia treatment.

Hypercholesterolemia Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Hypercholesterolemia treatment.

Hypercholesterolemia Market Outlook

The Hypercholesterolemia market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hypercholesterolemia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Hypercholesterolemia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Hypercholesterolemia market in 7MM is expected to change in the study period 2017-2030.

Key Findings

This section includes a glimpse of the Hypercholesterolemia market in 7MM.

The United States Market Outlook

This section provides the total Hypercholesterolemia market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Hypercholesterolemia market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Hypercholesterolemia market size and market size by therapies in Japan is also mentioned.

Download full report@ https://www.delveinsight.com/report-store/hypercholesterolemia-market

Hypercholesterolemia Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Hypercholesterolemia market or expected to get launched in the market during the study period 2017-2030. The analysis covers Hypercholesterolemia market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Hypercholesterolemia Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Hypercholesterolemia key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Hypercholesterolemia emerging therapies.

Reimbursement Scenario in Hypercholesterolemia

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Hypercholesterolemia domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Hypercholesterolemia market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Hypercholesterolemia Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

· The report covers the descriptive overview of Hypercholesterolemia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

· Comprehensive insight has been provided into the Hypercholesterolemia epidemiology and treatment in the 7MM

· Additionally, an all-inclusive account of both the current and emerging therapies for Hypercholesterolemia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

· A detailed review of Hypercholesterolemia market; historical and forecasted is included in the report, covering drug outreach in the 7MM

· The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hypercholesterolemia market

Report Highlights

· In the coming years, Hypercholesterolemia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market

· The companies and academics are working to assess challenges and seek opportunities that could influence Hypercholesterolemia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition

· Major players are involved in developing therapies for Hypercholesterolemia. Launch of emerging therapies will significantly impact the Hypercholesterolemia market

· A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Hypercholesterolemia

· Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Hypercholesterolemia Report Insights

· Patient Population

· Therapeutic Approaches

· Hypercholesterolemia Pipeline Analysis

· Hypercholesterolemia Market Size and Trends

· Market Opportunities

· Impact of upcoming Therapies

Hypercholesterolemia Report Key Strengths

· 11 Years Forecast

· 7MM Coverage

· Hypercholesterolemia Epidemiology Segmentation

· Key Cross Competition

· Highly Analyzed Market

· Drugs Uptake

Hypercholesterolemia Report Assessment

· Current Treatment Practices

· Unmet Needs

· Pipeline Product Profiles

· Market Attractiveness

· Market Drivers and Barriers

Reasons to buy

· The report will help in developing business strategies by understanding trends shaping and driving the Hypercholesterolemia market

· To understand the future market competition in the Hypercholesterolemia market and Insightful review of the key market drivers and barriers

· Organize sales and marketing efforts by identifying the best opportunities for Hypercholesterolemia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan

· Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors

· Organize sales and marketing efforts by identifying the best opportunities for Hypercholesterolemia market

· To understand the future market competition in the Hypercholesterolemia market

Request for sample pages

https://www.delveinsight.com/sample-request/hypercholesterolemia-market

#hypercholesterolemia market #hypercholesterolemia market share #hypercholesterolemia market size #hypercholesterolemia market research reports #hypercholesterolemia market trends #hypercholesterolemia

0 notes

ycdiabetes-blog · 7 years

Text

Truth About Cholesterol: MUST READ

One of the major concerns among diabetics is heart problems. Majority of the people suffering from diabetes deal with this complication and face the increased risk of heart failure in their lifetime. Remember the time you got diagnosed with diabetes; your doctor may have performed different test to confirm the disease. Among all the test report, you will find that they also checked your cholesterol levels, just reopen your medical report and I am sure you will find your cholesterol levels in the name of "lipid profile" But why the doctors checked your cholesterol level during diagnosis of diabetes (which is related to blood sugar)? Does cholesterol level indicate anything about your health? Are there any steps to control cholesterol levels? In this article, we will try to understand "what cholesterol is" and how it affects our health (especially for person living with diabetes) What is Cholesterol? Most of the people have heard the term cholesterol and they have preconceived notion that it is bad for our health. Even my 7-year-old neighbor have heard this term and knows that it is somewhat related to heart problems. Such awareness is all due to advertisements that we see on our television. Everyday me may come across ads of product which claims to be "cholesterol free" or "good for heart" Also, the increased cases of heart problems have given a lot of bad press to cholesterol and it has left no stone unturned to demonize it. But what if I tell you that the information/notion we have about cholesterol is half-baked and we are seriously failing to understand it fully. So lets first start with the basics; what is cholesterol? It is kind of a waxy substance that is found in our body cells. Is Cholesterol bad? How could it affect our health? There are different types of cholesterol and not all of them are bad. In fact, some of them are helpful and benefit our body in different ways. Most of us also believe that our food is the major contributor to develop cholesterol in our body, this idea is far away from the truth. Truth about cholesterol is that only 25% of the cholesterol comes from our diet and rest of it get produced from our body itself (our liver)!!!! So if cholesterol is so bad, then why our body make effort to produce it on its own? Because cholesterol provides certain health benefits, in fact, we cannot survive without cholesterol and if we reduce it to the low level, we will face various health issues. There are various studies that indicate that people with low cholesterol levels tend to have anger issues and are prone to depression. Cholesterol is needed by our body: 1.To form cell membranes/hormones/bile acid 2.Responsible for synapse formation which is required for neuron connections so that we can think or learn new things 3. Regulates serotonin (which affects our mood); in fact, it has been found that people with an extremely low level of cholesterol are prone to depression. Who could have thought that the cholesterol which we thought as a major culprit for heart attacks can be the cause of severe depression 4. Regulate cell process and protein pathway in cells So if cholesterol has so many benefits to offer, then why our doctors ask to stay away from it. Why there is so much bad press in media? Why then the companies are producing products that are "cholesterol-free"? In order to find if cholesterol is good or bad, we need to understand that the cholesterol is a very loose term and there are different types of it. Let me explain the different forms of cholesterol; whenever you revisit your lipid profile, you will definitely come across these terms; so if you are reading this article, take out your report and figure out the information yourself. 1. HDL (High-Density Lipoprotein): This cholesterol is good for you, it doesn't cause any harm and in fact, helps your body to remove arterial plaque (which cause heart problems) 2. LDL (Low-Density Lipoprotein): This is a bad cholesterol, it forms plaque in your arteries making it narrow and less flexible, which may cause heart attack or stroke. Now there are different sizes of LDL, the ones which are smaller in size cause more damage than large size LDL. 3. Triglycerides: These are the bad fats found in our blood and cause serious damage to our blood circulation system. Eating too much of refined sugar, grains and smoking cigarettes can raise the level of this cholesterol

Now, what are the right cholesterol levels? Generally, it has been stated by the doctors that total Cholesterol level below 200mg/dl and LDL below 100mg/dl are good numbers. But these numbers don't give us the complete picture. In other words, some people develop heart problems even if there total cholesterol level is below 200mg/dl and for some even high numbers may not cause any problems. But why this is so? Because the total cholesterol levels and LDL values don't give us complete pictures. Remember I told you that there are large LDL and Small LDL, and the smaller ones are more harmful. So suppose your LDL is 95mg/dl; this number will give you no information about how much large and small LDL's are within our body, so how can you predict that you are at high risk of getting the heart attack. In order to get more clarity about your body health, consider looking at the following parameters; a. HDL/Total Cholesterol Ratio: It's important for us to maintain certain level of "good cholesterol-HDL" in our body; Generally the percentage should be above 24% b. Triglyceride/HDL: The ratio should be around 2 This is the most important parameter judge your risk of heart health/stroke. Getting number beyond 2 will incidentally increase your risk of getting heart attack c. Fasting Blood Sugar Apart from the above two important ratios, it's been found that the fasting blood sugar can also indicate the risk of getting heart disease. People with fasting levels of 100-125 mg/dl blood sugar have 300% increased heart risk than people who maintain fasting sugar around 79mg/dl d. High Iron Level Large amount of iron in the body can also be damaging to your heart health; iron tends to cause oxidative stress in arteries and damages its functionality I have high numbers what should I do? If your numbers are high then you need to take steps immediately before the damage goes out of control. Here are the following few steps you can take: 1. Reduce/Eliminate Sugar and Grains from diet Sugar/Grain tends to increase triglyceride levels in the body. It is wise for you to reduce or completely eliminate from your diet. Our markets are full of products that contain high levels of processed sugar, even the daily food (like bread, roti, rice) we eat contribute heavily to develop unhealthy food in our body. Even the so-called healthy fruits are full of fructose and can seriously impact our health. Try to switch your diet to green vegetable or foods that contain healthy fat like avocados, green vegetables, grass-fed meat, eggs, etc which contain good fats. 2. Quit smoking Try to quit smoking; I know its easier said than done but believe me your effort in the right direction may certainly help. Try to join community center or organization that help people to quit, your small step can make huge difference in your health 3. Exercise Daily Always spare at least 30 minutes for workout FINAL WORD If you liked the article, please make sure to share with your diabetic community. If you want us to write on a particular topic, feel free to write us. You can also join our Facebook group by clicking the link below, the link will redirect you to our Group. FACEBOOK GROUP FURTHER READ Metformin Side effects Tips to control Diabetes Can diabetics eat dates? Read the full article

0 notes

aaalipio · 7 years

Text

How To Lower Cholesterol

What Is Cholesterol? We’ve all heard the word cholesterol. But what is it, and why is it bad for your health? Cholesterol is actually a natural substance that we all produce in our bodies. It is wax-like fat that helps the essential parts of our cells remain inside their walls while also allowing nutrients and chemicals to pass in either direction through the permeable membrane. Everyone produces cholesterol in their liver, but some of us make more than others. Diet also plays a key part in how much blood serum cholesterol a person has when the doctor checks their cholesterol levels through a blood test. Everyone wants to know how to lower cholesterol. We digest the food we eat with the help of bile from the liver, which helps break down the food into various components, including cholesterol. The cholesterol is then sent back to the liver. Anything the body does not use becomes a waste product which is excreted when we go to the bathroom. There are 4 main numbers looked at with regard to cholesterol: * Total cholesterol * LDL cholesterol-think L for Lousy * HDL cholesterol-think H for Helpful * Triglycerides Total cholesterol is HDL plus LDL. The optimal levels for each of these components is: Total - Less than 200 LDL-the lower the better - Less than 100 HDL-the higher the better - 60 or above Triglycerides 5 150 or below So what are these different measurements? Total cholesterol is made up of LDL and HDL. LDL, Low Density Lipoprotein (fat protein), cholesterol is made up of small particles that are dangerous because they can stick to the walls of blood vessels that have been damaged, or that are suffering from inflammation. Stress, medications, and certain conditions such as rheumatoid arthritis, can all trigger inflammationand make it difficult to reduce high cholesterol. One other component of LDL is VLDL, Very Low Density, which is even sticker than LDL because the molecules are so small. If the LDL sticks, it can block arteries, such as coronary arteries that supply the heart with blood to keep it healthy. If the supply is reduced or blocked, it can lead to a heart attack. Sometimes a clump of LDL can break off from the blood vessel walls and form a clot. Clots can travel throughout the body and get lodged in a narrowed blood vessel clogged with LDL cholesterol, commonly referred to as arterial plaque. If the clot goes to the heart, it can cause heart attack. If it goes to the brain, it will cause a stroke. If it travels to one of the arteries that supplies blood to the legs, it can cause tissue death. If the circulation is not restored in all of these cases, tissue death and eventually actual death will occur. So yiou see how important it is to answer the question, "how do I lower high cholesterol?" HDL, High Density Lipoprotein, is known as helpful cholesterol because its large particles can help clear clogged blood vessels by removing arterial plaque. Triglycerides Triglycerides are another type of fat used to store excess energy from the food you eat, especially animal proteins and sugary foods high in carbohydrates. They are also associated with hardening of the arteries. If the calories are not used, they get stored as fat, leading to obesity, which can cause heart health issues. Doctors often prescribe statins for people needing to lower high cholesterol in order to lower their total cholesterol and thus reduce their risk of a heart attack or stroke. However, most people taking statins are expected to take them for the rest of their lives In most cases, they are not given the option of trying to reduce high cholesterol levels through diet, exercise, weight loss and other natural methods, they are just told to take statins. Many people have heard of statins and probably even know people who are taking them, so if their doctor suggests a statin, they will rarely question the doctor’s recommendation. However, it is crucial to understand all the medicines you ever take, why you are taking them, how long for, and what the potential side effects can be. For some patients, the side effects of statins are so severe it will not be worth it for them to take them. For others, they will need to balance the benefits with the risks, some of which may be long-term.

But can cholesterol be lowered long-term? Statins are the most commonly prescribed class of drugs in the world, with the #1 seller the cholesterol-lowering drug Lipitor (atorvastatin). They are commonly prescribed under the assumption that they can help protect heart health and lower the risk of heart attack. However, as with all medicines, they carry a risk of side effects. Statins were first discovered in the 1980s, and Lipitor was the first to win U.S. Food and Drug Administration (FDA) approval in 1987. The original protocol was to only prescribe the drug if the patient had made significant lifestyle changes such as diet but was still unable to get their cholesterol down to heart healthy levels. However, Lipitor soon became a cash cow that was far too easy to milk. It became part of a ‘one pill fits all approach’ for anyone who had high cholesterol. Other statins soon emerged and jockeyed for market share, but as more and more post-approval studies for statins emerged, so too did a growing number of side effects and risks that patients had suffered as a result of taking the medication. As with all drugs, both prescription and over the counter, it is always a case of balancing risk on the one hand with benefits on the other. In the case of many medications, however, the patient is not being give the full facts needed to make intelligent decisions and what is termed informed consent. In this guide, you will discover what cholesterol is, how statins lower blood serum cholesterol, and what major risks and side effects have been reported in relation to statins. You will also discover easy, natural ways to reduce cholesterol in your diet so you can decide for yourself whether statins are worth the risk or whether you can go the all-natural route. Let’s start with what cholesterol is and how to lower cholesterol.

can cholesterol be lowered

0 notes

market-research-future · 4 years

Text

Cholesterol Management Devices Market Future Outlook, Emerging Trends

Market Key Players

The Global cholesterol management devices market by size and share is projected to grow at a CAGR of 8.5% during the forecasted period 2017-2023.

Market Highlights

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4160

Cholesterol Management Devices Market Segmentation:

Cholesterol Management Devices Market Regional Analysis

Geographically, the global cholesterol management devices Market is categorized into America, Europe, Asia Pacific and the Middle East & Africa.

Browse Detailed Table of Content at: https://www.marketresearchfuture.com/reports/cholesterol-management-devices-market-1045

Brows More Healthcare Related Research Reports

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

Nanobots Market Size, Trends | Insights and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

strategyr-blog · 7 years

Text

The Global Market for Cholesterol Screening and Lab Testing Services is Projected to Reach US$17.4 Billion by 2024

Growing Risk of Cardiovascular Disease Amid Surge in Obesity, Diabetes and Hypertension Cases Drives the Global Cholesterol Testing Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segment, trends, growth drivers, market share, size and demand forecasts on the global Cholesterol Testing market. The global market for Cholesterol Screening and Lab Testing Services is projected to reach US$17.4 billion by 2024, driven by rising prevalence of Cardiovascular Diseases amid growing incidence of obesity, diabetes, and hypertension, and ageing population.

Cholesterol is a naturally occurring white crystalline lipid that is generally present in human body. Synthesized by the liver, cholesterol plays a crucial role as a vital constituent of cell membranes and is required for the production of steroid hormone and bile acids. Although, cholesterol is vital for proper functioning of the body, excess levels of cholesterol, found mainly as low-density lipoprotein (LDL), pose a health risk. Also known as ‘bad’ cholesterol, LDL is a known risk factor for cardiovascular diseases (CVDs) such as coronary heart disease, rheumatic heart disease, stroke and high blood pressure (hypertension). Given the fatal impact of CVDs, cholesterol screening tests are a compulsion for people deemed to be at risk of these diseases. Different types of tests are carried out to quantify the level of cholesterol such as Complete Lipid Profile / Lipid Panel Test, Apolipoprotein B, and Apolipoprotein A1 among others.

Demand for cholesterol screening and lab testing services continues to increase across the world, primarily stimulated by growing awareness over the importance of cholesterol screening as a measure to reduce fatality and improve diagnosis and treatment of CVD. Pressing need for regular cholesterol testing among people with family history of heart disease, individuals with diabetes and obesity, and aged people, who are regarded to be at the risk of cardiovascular disease, is aiding the demand for cholesterol testing. Further, cholesterol testing market is also benefiting from prevailing macro trends in the global healthcare sector such as increasing healthcare expenditure, wider availability of care/diagnostics services, growing health-consciousness and lenience towards preventive care among urban population. While the number of patients seeking cholesterol screening based on doctor’s recommendation continues to grow substantially, volumes of consumer-initiated tests also saw incremental growth in recent years. Uptrend in cholesterol testing is immensely benefiting the commercial diagnostics centers, hospitals with in-house laboratories, and other entities offering diagnostics services. On the other hand, growing popularity of self-testing home kits, which can be operated by patient himself to precisely generate cholesterol levels, is niggling the market prospects of full-service diagnostics services providers.

As stated by the new market research report on Cholesterol Testing, United States ranks as the largest market, worldwide. On the other hand, Asia-Pacific represents the fastest growing regional market, trailing at a CAGR of 13.3% over the analysis period. Rising disposable incomes, coupled with increasing urbanization, growing health consciousness, aging population, and awareness of the need for cardiovascular risk assessments are fuelling demand for cholesterol screening services in the Asia-Pacific region. The market is also benefiting from focused investments on improving healthcare infrastructure and growing base of at-risk population in China and India.

Key players in the market include Abbott Laboratories, AccuTech LLC, Akers Biosciences Inc., Alere Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific, Home Access Health Corporation, Laboratory Corporation of America® Holdings, PRIMA Lab SA, PTS Diagnostics, Quest Diagnostics Inc., Randox Laboratories Ltd., Roche Diagnostics, Sekisui Diagnostics LLC, Siemens Healthineers, and Sigma-Aldrich Corp. among others.

The research report titled “Cholesterol Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in dollars for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World.

To connect with us, visit our LinkedIn page.

#Cholesterol Testing #Clinical Diagnostics

0 notes

kisan512posts · 4 years

Text

Cardiac Biomarkers -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

Cardiac Biomarkers Industry

Description

Wiseguyreports.Com Adds “Cardiac Biomarkers -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3260776-cardiac-biomarkers-technologies-and-global-markets

Report Scope

Leave a Query @ https://www.wiseguyreports.com/enquiry/3260776-cardiac-biomarkers-technologies-and-global-markets

Report Includes

Table of Contents

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3260776

Continued…

0 notes

clevertimetravelpaper · 2 years

Text

Lipid Profile Market Trends, Forecast, Demand, Supply, Technology, Trends, Size, and Opportunity Assessment to 2027

Lipid profile market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.40% in the above-mentioned forecast period. Increasing awareness amongst the patients regarding their health along with rising cholesterol level will help in driving the growth of the market.

Increasing number of geriatric as well as obese population across the globe, rising cases of cardiovascular diseases as well as diabetes, surging level of funds for the development of advanced and technologically innovative testing product, adoption of non-invasive procedures are some of the factors that will likely to enhance the growth of the lipid profile market in the forecast period of 2020-2027. On the other hand, improved distribution channel along with adoption of POC diagnostics which will further boost various opportunities that will lead to the growth of the lipid profile market in the above mentioned forecast period. Lack of awareness among the people regarding new treatment method in developing economies which will hamper the growth of the lipid profile market in the above mentioned forecast period.

Get a Sample PDF of the report –https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lipid-profile-market

This lipid profile market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lipid profile market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lipid Profile Market Scope and Market Size

Lipid profile market is segmented on the basis of type, indication, technology, distribution channel, medication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on type, lipid profile market is segmented into total cholesterol, LDL (low-density lipoprotein), HDL (high-density lipoprotein), and triglycerides.

On the basis of indication, lipid profile market is segmented into high blood pressure, genetic disease, diabetes, obesity, and others.

Based on technology, lipid profile market is segmented into PCR based, ELISA, and others.

On the basis of distribution channel, lipid profile market is segmented into online, retail, and direct tender.

Based on medication, lipid profile market is segmented into statins, niacin, fibrates, zetia, and bile acid sequestrants.

Lipid profile market has also been segmented based on the end user into clinics, hospitals, ambulatory centers, homecare, and diagnostic centers.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@- https://www.databridgemarketresearch.com/reports/global-lipid-profile-market

Lipid Profile Market Country Level Analysis

Lipid profile market is analysed and market size insights and trends are provided by country, type, indication, technology, distribution channel, medication and end user as referenced above. The countries covered in the lipid profile market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the lipid profile market due to the adoption of advanced technology as well as rising geriatric and obese population, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the growing number of aging population along with changing lifestyle of the people.

The country section of the lipid profile market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Lipid Profile Market Share Analysis

Lipid profile market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lipid profile market.

The major players covered in the lipid profile market report are Abbott., Akers Biosciences, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific, Boston Heart Diagnostics Corporation, F. Hoffmann-La Roche Ltd, Home Access Health, Laboratory Corporation of America Holdings., PRIMA Lab SA, Polymer Technology Systems, Inc., Quest Diagnostics Incorporated., Randox Laboratories Ltd., Sekisui Diagnostics, Siemens Healthcare Private Limited, Merck KGaA, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse the complete table of contents at- https://www.databridgemarketresearch.com/toc/?dbmr=global-lipid-profile-market

Related Reports:

North America Compression Therapy Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/north-america-compression-therapy-market

Europe Compression Therapy Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/europe-compression-therapy-market

Asia-Pacific Compression Therapy Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-compression-therapy-market

Cold Compression Therapy Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-cold-compression-therapy-market

Capillary Blood Collection Devices Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-capillary-blood-collection-devices-market

Venous Blood Collection Devices Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-venous-blood-collection-devices-market

Laser Doppler Blood Flow Measurement Devices Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-laser-doppler-blood-flow-measurement-devices-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- [email protected]

0 notes

market-research-future · 4 years

Text

Cholesterol Management Devices Market Profile, Key Players, Dynamics By 2023

Cholesterol Management Devices Market Segmentation:

Cholesterol Management Devices Market Regional Analysis

Geographically, the global cholesterol management devices Market is categorized into America, Europe, Asia Pacific and the Middle East & Africa.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4160

Market Highlights

Browse Detailed Table of Content at: https://www.marketresearchfuture.com/reports/cholesterol-management-devices-market-1045

Market Key Players

The Global cholesterol management devices market by size and share is projected to grow at a CAGR of 8.5% during the forecasted period 2017-2023.

Brows More Healthcare Related Research Reports

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

Nanobots Market Size, Trends | Insights and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

market-research-future · 4 years

Text

Cholesterol Management Devices Market Insights, Solutions and Services By 2023

Cholesterol Management Devices Market Segmentation:

Cholesterol Management Devices Market Regional Analysis

Geographically, the global cholesterol management devices Market is categorized into America, Europe, Asia Pacific and the Middle East & Africa.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4160

Market Highlights

Browse Detailed Table of Content at: https://www.marketresearchfuture.com/reports/cholesterol-management-devices-market-1045

Market Key Players

The Global cholesterol management devices market by size and share is projected to grow at a CAGR of 8.5% during the forecasted period 2017-2023.

Brows More Healthcare Related Research Reports

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

Nanobots Market Size, Trends | Insights and Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes